| Ytd | -20.00% | |
| 1y | -6.06% |
| Open | 1.22 | Prev Close | 1.21 | Low | 1.20 | High | 1.26 | Mkt Cap | 132.83M |
| Vol | 0.00 | Avg Vol | 1.27M | EPS | -0.34 | P/E | -3.65 | Forward P/E | -10.41 |
| Beta | 1.16 | Short Ratio | 4.08 | Inst. Own | 70.20% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-12 | 50-d Avg | 1.19 | 200-d Avg | 1.15 | 1yr Est | 8.67 |
MaxCyte, Inc. (NASDAQ:MXCT), a leading cell-engineering company providing enabling platform technolo
ROCKVILLE, Md., July 21, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engin
ROCKVILLE, Md., July 15, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng
Gainers Vicore Pharma Holding (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-m
ROCKVILLE, Md. & CHICAGO--(BUSINESS WIRE)-- #BioTechNews--VectorBuilder, a global leader in gene del
MaxCyte, Inc. (MXCT) Q1 2026 Earnings Call Transcript
MaxCyte NASDAQ: MXCT reported lower first-quarter revenue compared with the prior year, as managemen
MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Es
First quarter 2026 total revenue of $9.7 million, including $6.2 million of core revenue and $3.4 mi
ROCKVILLE, Md., April 29, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-en
MaxCyte, Inc. (NASDAQ: MXCT - Get Free Report) has been assigned a consensus rating of "Hold" from t
ROCKVILLE, Md., March 31, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engi
MaxCyte (NASDAQ: MXCT) executives told investors the company made "meaningful progress" in 2025 desp
MaxCyte, Inc. (MXCT) Q4 2025 Earnings Call Transcript
MaxCyte, Inc. (MXCT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Es
Fourth quarter 2025 total revenue of $7.3 million at the top of the range of previous preliminary an
ROCKVILLE, Md., March 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell-engi
ROCKVILLE, Md., Feb. 24, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng
ROCKVILLE, Md., Feb. 23, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-eng
ROCKVILLE, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: MXCT), a leadi
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cellares, the first Integrated Development and Manufac
MaxCyte, Inc. ( MXCT ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Mahe
Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for it
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its
Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company
On Thursday, 369 companies hit new 52-week lows.
On Tuesday, 647 companies set new 52-week lows.
During the session on Thursday, 461 stocks hit new 52-week lows.
During Tuesday's session, 275 companies made new 52-week lows.
Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earni
Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly
Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is estimated to report earnings for i
On Tuesday, 951 companies hit new 52-week lows.
During Monday's trading, 1214 companies set new 52-week lows.
On Friday, 422 stocks made new 52-week lows.
On Wednesday, 807 companies reached new 52-week lows.